ArticleOpen forum infectious diseases2026
Clinical Characteristics and Severity of Rhinovirus/Enterovirus-Associated Hospitalizations: A Multicountry Analysis From the Global Influenza Hospital Surveillance Network, 2017-2024.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rhinoviruses and enteroviruses (RV/EV) are frequently detected in hospitalized patients with acute respiratory illness; yet, their clinical burden remains under-characterized, particularly across diverse populations and age groups. Methods: We analyzed Global Influenza Hospital Surveillance Network data collected from November 2017 through October 2024 across 13 countries representing high-, upper-middle-, and lower-middle-income settings. Multivariable mixed-effects logistic regression models, stratified by age (<5, 5-64, ≥65 years) and adjusted for sex, comorbidities, influenza coinfection, country income level, and season, identified risk factors for mechanical ventilation and in-hospital death. Results: Among 7929 RV/EV-positive patients, 62.7%, 24.3%, and 13.0% were aged <5, 5-64, and ≥65 years, respectively. In-hospital death was 6.3% among adults aged 65-74 years and 9.2% among those aged ≥75 years. In children aged <5 years, comorbidities strongly predicted mechanical ventilation (adjusted odds ratio [aOR] for ≥2 comorbidities = 4.62, 95% CI: 2.30-9.28) and death (aOR for 1 comorbidity = 3.38, 95% CI: 1.29-8.88). Among adults aged ≥65 years, age ≥75 years predicted in-hospital death (aOR = 2.66, 95% CI: 1.43-4.94). Children aged <5 years from lower-middle-income countries had 10-fold higher probability of in-hospital death than those from high-income countries (aOR = 9.94, 95% CI: 1.87-52.70), the same disparity was seen among older adults from lower-middle-income countries (aOR = 6.83, 95% CI: 1.80-25.88). Conclusions: Rhinoviruses and enteroviruses infections contribute substantially to severe respiratory disease among hospitalized patients globally, with particularly severe outcomes at both extremes of age and marked inequalities in lower-middle-income countries. Rhinoviruses/enteroviruses warrant integration into respiratory virus surveillance and public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.